APGN

Apexigen, Inc. APGN

Trading inactive

APGN
Apexigen, Inc. IMVIF
IMV Inc. SCPX
Scorpius Holdings, Inc. BTHE
Boston Therapeutics, Inc. TSBX
Turnstone Biologics Corp. KRRO
Korro Bio, Inc. ALNA
Allena Pharmaceuticals, Inc. AMTI
Applied Molecular Transport Inc. CHRO
Channel Therapeutics Corporation OBSV
ObsEva S.A.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode APGN IMVIF SCPX BTHE TSBX KRRO ALNA AMTI CHRO OBSV
6M -38.57 % 0.00 % -84.29 % 0.00 % -1.31 % 209.02 % -38.12 % -15.43 % -94.23 % -44.97 %
YTD -40.75 % 0.00 % -99.84 % 0.00 % -33.95 % 2.75 % 0.00 % 0.00 % -81.33 % -35.16 %
1Y -93.88 % 0.00 % -99.93 % 0.00 % -46.69 % -44.44 % -81.39 % -56.89 % -87.38 % -92.78 %
3Y -96.38 % -100.00 % -100.00 % 0.00 % -96.77 % -49.82 % -96.79 % -99.34 % -97.19 % -95.24 %
5Y -96.38 % -100.00 % -100.00 % 0.00 % -96.77 % -96.03 % -98.85 % -98.54 % -97.19 % -99.32 %
10Y -96.38 % -100.00 % -100.00 % 0.00 % -96.77 % -93.85 % -99.25 % -98.54 % -97.19 % -99.22 %
From the beginning -96.38 % -100.00 % -100.00 % 0.00 % -96.77 % -93.85 % -99.25 % -98.54 % -97.19 % -99.22 %

Dividend